Navigation Links
DaVita Abstracts Accepted into American Society of Nephrology Meeting

Fifteen Abstracts Will Be Featured at ASN

EL SEGUNDO, Calif., Nov. 4 /PRNewswire/ -- DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research(R) (DCR), recently contributed fifteen abstracts to the 41st Annual Meeting & Scientific Exposition of the American Society of Nephrology. These abstracts were developed both internally and through intellectual partnerships with leaders in nephrology.


DaVita Chief Medical Officer, Allen R. Nissenson, MD, FACP, FASN and Emeritus Professor of Medicine at the David Geffen School of Medicine at UCLA states, "DaVita is committed to improving the lives of patients with kidney disease. Generating new knowledge through research is an important component of meeting this commitment. The Office of the Chief Medical Officer (OCMO) in its Relentless Pursuit of Quality will continue to work closely with DCR and our external academic partners to significantly impact patient outcomes through clinical research."

The American Society of Nephrology (ASN) is organized and operated primarily for scientific and educational purposes, and advocates for the development of national health policies to improve the quality of care for renal patients. Renal Week 2008 is November 4-9 in Philadelphia, PA. DaVita Clinical Research collaborates with leading academic institutions to advance the knowledge and practice of kidney care for dialysis patients.

The abstracts featured include:

-- Association of Low Body Mass Index (BMI) and Weight Loss with Increased Mortality in Transplant-Wait-Listed Maintenance Hemodialysis Patients

Kamyar Kalantar-Zadeh, MD PhD; Elani Streja, MPH; Jennie Jing, MS; Csaba P. Kovesdy, MD; David Van Wyck, MD; Gabriel M. Danovitch, MD; and Suphamai Bunnapradist, MD.

-- Association Between Laboratory Surrogates of Renal Osteodystrophy and ESA Responsiveness in Maintenance Hemodialysis Patients

Kamyar Kalantar-Zadeh, MD PhD; Deborah L. Regidor, PhD; Jennie Jing, MS; David Van Wyck, MD; and Csaba P. Kovesdy, MD.

-- Survival Benefit Associated with Cinacalet Use in a Large Cohort of Hemodialysis patients with Secondary Hyperparathyroidism

Geoffrey Block, MD; Gerard Smits, PhD; Martha Persky, RN; Stephanie Brillhart; Jiannong Liu; and Wendy St-Peter.

-- Risk Factors Associated with Sudden Cardiac Arrest in Hemodialysis Patients: A Case-Control Study

Patrick H Pun, MD; Ruediger Lehrich, MD; Emily Honeycutt, MS; Linda Shaw, MS; and John P Middleton, MD.

-- Catheter Removal is Associated with Improved Serum Albumin Levels in Maintenance Hemodialysis Patients

Debbie Benner, MA RD CSR; Ram Dukkipati, MD; Joe Weldon, MBA; David Van Wyck, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Mortality Predictability of the 5-Year Time-Averaged Serum Calcium in 151,555 Maintenance Hemodialysis Patients

Jessica E. Miller, MPH; Csaba P. Kovesdy, MD; David Van Wyck, MD; Joel D. Kopple, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Greater Fluid Retention is Associated with Higher Mortality in Maintenance Hemodialysis Patients

Deborah L. Regidor, PhD; Csaba P. Kovesdy, MD; Suphamai Bunnapradist, MD; David Van Wyck, MD; Tamara B. Horwich, MD; Gregg C. Fonarow, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Independent Association of Hemodialysis Treatment Session Time and 5-Year Survival in 88,153 Maintenance Hemodialysis Patients

Jessica E. Miller, MPH; Csaba P. Kovesdy, MD; Jennie Jing, MS; David Van Wyck, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Association between Time-Averaged (Cumulative) Hemodialysis Dose and 5-year Survival CKD Patients

Jessica E. Miller, MPH; Elani Streja, MPH; Csaba P. Kovesdy, MD; David Van Wyck, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Higher Body mass Index (BMI) at the Time of Transplantation is Associated with Greater 5.Year Patient and Graft Survival in 8,529 Renal Transplant Recipients

Elani Streja, MPH; Suphamai Bunnapradist, MD; Csaba P. Kovesdy, MD; Gabriel M. Danovitch, MD; David Van Wyck, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Association of Low Serum Calcium with ESA Hypo-Responsiveness in Hemodialysis Patients

Deborah L. Regidor, PhD; Jennie Jing, MS; David Van Wyck, MD; Csaba P. Kovesdy, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Can Better Nutritional Status Explain Greater Survival of Hispanic Hemodialysis Patients?

Elani Streja, MPH; Stephen F. Derose, MD MPH; Steven J. Jacobsen, MD PhD; Scott Rasgon, MD; Csaba P. Kovesdy, MD; David Van Wyck, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Managing the Complexities of CKD Mineral and Bone Disorders: A Unique Tool

Debbie Benner, MA RD CSR; Mary Burgess, RD; Allen Nissenson, MD; and David Van Wyck, MD.

-- Clinical Performance in a Large Dialysis organization: Effect of Length of Facility Ownership

David Van Wyck, MD; John Robertson, MD; Allen Nissenson, MD; Robert Provenzano, MD; and Dennis Kogod.

-- Erythrocyte Membrane fatty acid composition in ESRD patients

Charles Kert, MD; Peter Klementowicz, MD; Joyce Clouser, RD; and William S. Harris, PhD.

DCR, through its commitment to quality, timely and accurate clinical trials, plays a valuable role by partnering with physicians, pharmaceutical and biotechnology companies to develop and progress new drug therapies for patients diagnosed with CKD.

DaVita and DaVita Clinical Research are registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,400 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 110,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials, and its community programs, please visit

SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita Receives Civil Complaint
2. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
3. DaVita Teammates Bicycling 230 Miles for Kidney Disease Education
4. DaVita Volunteers Raise More than $1,000,000 for Nationwide Kidney Education and Prevention Programs
5. DaVita Emergency Response Efforts Ensure Vital Treatment for More than 700 Kidney Failure Patients in Need of Life-Saving Dialysis Treatments in Areas Affected by Southern California Wildfires
6. DaVita to Open First Independent Dialysis Clinic in Fargo-Moorhead
7. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
8. DaVita Inc. to Present at JPMorgan Healthcare Conference
9. DaVita and Phoenix-Based Southwest Kidney Institute Form Broad Partnership
10. Nations Leading Dialysis Provider - DaVita - Partners with eDiets(R) to Launch One-of-a-Kind Diet Helper Online Nutrition and Meal Planning Tool for Late-Stage Kidney Disease Patients and Caregivers
11. DaVita Announces Chief Financial Officer
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Jobs in hospital medical ... professionals and offered by healthcare staffing agency Aureus Medical Group . ... of October 2015 among those searching for healthcare jobs through the company’s website, ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the first ... annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the International ... November 11th, 2015. The conference was held at the Hawaii Convention Center in ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... and wellness consultation, has collaborated with Women’s Web – an online resource ... on topics on mental and emotional well-being relationship, life balance, stress, professional ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast cancers found with ... according to a study published online in the journal Radiology. Researchers said that ... necessitate a change in treatment. , Breast MRI is the most sensitive technique ...
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday ... dish and pleasing the palates of attendees is of the utmost importance. Whether ... a seasonal get-together, give these recipes a try this holiday season. , Turkey ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Calif. , Nov. 25, 2015  Amgen (NASDAQ: ... Biologics License Application (BLA) with the United ... for ABP 501, a biosimilar candidate to Humira ® ... adalimumab biosimilar application submitted to the FDA and represents ... Sean E. Harper , M.D., executive vice ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma ... planned investment of at least $15.8  Million to ... Wilmington, NC . The expansion will ... to meet the growing demands of the pharmaceutical ... site expansion will provide up to 40,000 ...
(Date:11/25/2015)... Nov. 25, 2015  Henry Schein, Inc., the world,s ... office-based dental, medical and animal health practitioners, will unveil ... Henry Schein ConnectDental® Pavilion , which brings together ... open solutions designed to help any practice or laboratory ... for a schedule of experts appearing at the ...
Breaking Medicine Technology: